NDP-MSH rescues LPS-induced neuroinflammation, synaptic deficits, and depressive-like behaviors in mice: involvement of MC1R-cAMP/PKA signaling.
Overview
- School of Pharmacy, Faculty of Health and Medical Sciences, Taylor’s University, Subang Jaya, Selangor, Malaysia
- School of Medicine, Dali University, Dali, Yunnan, China
- School of Medicine, Xinjiang College of Science and Technology, Korla, China
- Department of Pharmaceutical Life Sciences, Faculty of Pharmacy, Universiti Malaya, Kuala Lumpur, Malaysia
Abstract
Introduction: Inflammatory processes contribute significantly to the pathophysiology of depression. Although the melanocortin system is well known to regulate inflammation, the specific contribution of melanocortin 1 receptor (MC1R) and its endogenous ligand, α-melanocyte-stimulating
Methods: Systemic lipopolysaccharide (LPS) administration was used to establish an inflammation-associated depression model in mice. Depressive-like behaviors, synaptic functions, and metabolic alterations were evaluated using behavioral tests, patch-clamp recordings, and untargeted metabolomic profiling. To examine the functional involvement of MC1R, adeno-associated virus (AAV)-mediated selective Mc1r overexpression was performed in the medial prefrontal cortex (mPFC).
Results: LPS administration induced depressive-like behaviors in mice, accompanied by microglial activation and a significant reduction in MC1R expression in the prefrontal cortex (PFC). Treatment with MC1R endogenous ligand α-MSH mimetic Nle4-DPhe7-α-MSH (NDP-MSH) markedly attenuated LPS-induced depressive-like behaviors, enhanced MC1R, postsynaptic density protein 95 (PSD95), glutamate receptor 1 (GluA1) and protein kinase A (PKA) phosphorylation. PKA inhibitor H89-mediated inhibition of the cyclic adenosine monophosphate/
Conclusion: This study highlights MC1R-related signaling in the PFC as an important contributor to inflammation-associated depression and suggests that NDP-MSH alleviates inflammation-associated depressive-like behaviors in association with melanocortin signaling involving MC1R and downstream cAMP/
Reproduced under the paper's license (CC BY), from the paper cited above.
Code
The paper links to its data and to no code of its authors: see the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none, so it has no map.
Data
Datasets cited
- doi:10.17632/
8rsxrhfp68.1 , at the source; found in “Data availability statement”
Data availability statement
The untargeted metabolomics datasets generated and analyzed during the current study are publicly available in the Mendeley Data repository at https://
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 27 September 2026: the first record
Recorded: type, language, journal, volume, pages, dates, 12 authors, 5 keywords, 1 funder, 57 references.
Cite
This paper
Qu, S., Peng, X., Ji, J., He, E., Jiang, L., Ma, R., Li, H., Li, Y., Li, L., Yow, H.-Y., Hamzah, S., & Gong, Z. (2026). NDP-MSH rescues LPS-induced neuroinflammation, synaptic deficits, and depressive-like behaviors in mice: involvement of MC1R-cAMP/
BibTeX
@article{qu2026ndp,
author = {Qu, Shanglan and Peng, Xin and Ji, Jieyu and He, Ershu and Jiang, Le and Ma, Ruixue and Li, Hanwei and Li, Yanjiao and Li, Lijuan and Yow, Hui-Yin and Hamzah, Sharina and Gong, Zhiting},
title = {{NDP-MSH rescues LPS-induced neuroinflammation, synaptic deficits, and depressive-like behaviors in mice: involvement of MC1R-cAMP/
journal = {Frontiers in pharmacology},
year = {2026},
month = aug,
volume = {17},
pages = {1895800},
publisher = {Frontiers Media SA},
issn = {1663-9812},
doi = {10.3389/
url = {https://
pmid = {42621255},
pmcid = {PMC13487505}
}
RIS
TY - JOUR
AU - Qu, Shanglan
AU - Peng, Xin
AU - Ji, Jieyu
AU - He, Ershu
AU - Jiang, Le
AU - Ma, Ruixue
AU - Li, Hanwei
AU - Li, Yanjiao
AU - Li, Lijuan
AU - Yow, Hui-Yin
AU - Hamzah, Sharina
AU - Gong, Zhiting
TI - NDP-MSH rescues LPS-induced neuroinflammation, synaptic deficits, and depressive-like behaviors in mice: involvement of MC1R-cAMP/
T2 - Frontiers in pharmacology
J2 - Front Pharmacol
PY - 2026
DA - 2026/
VL - 17
SP - 1895800
SN - 1663-9812
PB - Frontiers Media SA
DO - 10.3389/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.3389/
"type": "article-journal",
"title": "NDP-MSH rescues LPS-induced neuroinflammation, synaptic deficits, and depressive-like behaviors in mice: involvement of MC1R-cAMP/
"container-title": "Frontiers in pharmacology",
"author": [
{
"family": "Qu",
"given": "Shanglan"
},
{
"family": "Peng",
"given": "Xin"
},
{
"family": "Ji",
"given": "Jieyu"
},
{
"family": "He",
"given": "Ershu"
},
{
"family": "Jiang",
"given": "Le"
},
{
"family": "Ma",
"given": "Ruixue"
},
{
"family": "Li",
"given": "Hanwei"
},
{
"family": "Li",
"given": "Yanjiao"
},
{
"family": "Li",
"given": "Lijuan"
},
{
"family": "Yow",
"given": "Hui-Yin"
},
{
"family": "Hamzah",
"given": "Sharina"
},
{
"family": "Gong",
"given": "Zhiting"
}
],
"container-title-short":
"volume": "17",
"page": "1895800",
"DOI": "10.3389/
"PMID": "42621255",
"PMCID": "PMC13487505",
"ISSN": "1663-9812",
"publisher": "Frontiers Media SA",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
8,
5
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1007/s11481-023-10094-7
- Peripheral MC1R Activation Modulates Immune Responses and is Neuroprotective in a Mouse Model of Parkinson's Disease.Journal: Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune PharmacologyIn common: mouse, cellular / molecular, 3 references
- [2] doi:10.1016/j.xcrm.2024.101798
- Bifidobacteria with indole-3-lactic acid-producing capacity exhibit psychobiotic potential via reducing neuroinflammation.Journal: Cell reports. MedicineIn common: depression, mouse, cellular / molecular, 2 references
- [3] doi:10.1186/s10020-025-01217-2
- Formononetin ameliorates depression-like behaviors through rebalancing microglia M1/
M2 polarization and inhibiting NLRP3 inflammasome: involvement of activating PPARα-mediated autophagy. Journal: Molecular medicine (Cambridge, Mass.)In common: depression, mouse, cellular / molecular, 2 references - [4] doi:10.1038/s41586-025-08807-4
- Stress dynamically modulates neuronal autophagy to gate depression onset.Journal: NatureIn common: depression, mouse, cellular / molecular, 2 references
- [5] doi:10.3389/fimmu.2022.810582
- Didymin Suppresses Microglia Pyroptosis and Neuroinflammation Through the Asc/
Caspase-1/ GSDMD Pathway Following Experimental Intracerebral Hemorrhage. Journal: Frontiers in immunologyIn common: mouse, cellular / molecular, 2 references - [6] doi:10.1016/j.isci.2023.107878
- The PrL<sup>Glu</
sup>→avBNST<sup>GABA</ sup> circuit rapidly modulates depression-like behaviors in male mice. Journal: iScienceIn common: depression, mouse, 2 references - [7] doi:10.3389/fnut.2025.1652968
- Danggui Shaoyao San attenuates depressive-like behaviors in mice via TLR4/
NF-κB p65/ JAK-STAT3/ AKT-GSK3β signaling pathways: modulation of hippocampal neurogenesis and neuroinflammation. Journal: Frontiers in nutritionIn common: depression, mouse, 2 references - [8] doi:10.1016/j.ceca.2024.102923
- ER and SOCE Ca&
lt;sup& gt;2+& lt;/ sup& gt; signals are not required for directed cell migration in human iPSC-derived microglia. Journal: Cell calciumIn common: cellular / molecular, 2 references - [9] doi:10.3390/cimb46030133
- Melanocortin Derivatives Induced Vascularization and Neuroglial Proliferation in the Rat Brain under Conditions of Cerebral Ischemia.Journal: Current issues in molecular biologyIn common: 2 references
- [10] doi:10.3390/neurolint18070133 [code]
- Therapeutic Advances in Major NBIA Disorders: Current Strategies and Translational Challenges.Journal: Neurology internationalIn common: 2 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
